Annals of Clinical Microbiology, The official Journal of the Korean Society of Clinical Microbiology

6

Weeks in Review

2

Weeks to Publication
Indexed in KCI, KoreaMed, Synapse, DOAJ
Open Access, Peer Reviewed
pISSN 2288-0585 eISSN 2288-6850

Fig. 2. AMRs of Acinetobacter baumannii in various clinical conditions. (A) CA versus HA, (B) ICU versus non-ICU-admitted patients, (C) inpatients versus outpatients. *Statistically significant (P-value < 0.05). Abbreviations: AMR, antimicrobial resistance rates; CA, communityacquired infection; HA, healthcare-associated infection; ICU, intensive care unit; PIP, piperacillin; TZP, piperacillin-tazobactam; SAM, ampicillin-sulbactam; CAZ, ceftazidime; FEP, cefepime; IPM, imipenem; MEM, meropenem; AMK, amikacin; GEN, gentamicin; TOB, tobramycin; CIP, ciprofloxacin; MIN, minocycline; TGC, tigecycline; CST, colistin

Ann Clin Microbiol 2022;25:137-145. Antimicrobial resistance patterns of Acinetobacter baumannii and Pseudomonas aeruginosa isolated from vulnerable patients in Korea, 2021

Fig. 1. AMRs of Acinetobacter baumannii (A) and Pseudomonas aeruginosa blood isolates (B). Abbreviations: AMR, antimicrobial resistance rates; PIP, piperacillin; SAM, ampicillin-sulbactam; TZP, piperacillin-tazobactam; CAZ, ceftazidime; FEP, cefepime; IPM, imipenem; MEM, meropenem; AMK, amikacin; GEN, gentamicin; TOB, tobramycin; CIP, ciprofloxacin; MIN, minocycline; TGC, tigecycline; CST, colistin; AZT, aztreonam.

Ann Clin Microbiol 2022;25:137-145. Antimicrobial resistance patterns of Acinetobacter baumannii and Pseudomonas aeruginosa isolated from vulnerable patients in Korea, 2021

Fig. 1. Differences between the old & new AST algorithm of the QMAC-dRAST. The new AST algorithm judges that bacterial growth is inhibited if there is no decrease in the brightness of the image. In the new AST algorithm, bacterial growth is considered to have occurred actually only when the brightness of the image decreased. AST, antimicrobial susceptibility testing.

Ann Clin Microbiol 2022;25:109-118. Clinical usefulness of the QMAC-dRAST system for AmpC β-lactamase-producing Enterobacterales

Table 1. DST results from three institutes

Ann Clin Microbiol 2023;26:139-145. Comparative evaluation of critical concentrations for detecting borderline rifampin resistance in Mycobacterium tuberculosis Drugs (CCs) SMC SNUBH SCL Total S R S R S R S R RIF (0.5 μg/mL) 172 5 148 2 1,238 31 1,558 38 RIF (1.0 μg/mL) 172 5 148 2 1,241 28 1,561 35 INH (0.1/0.2 […]

Table 2. Performance of the FilmArray pneumonia panel plus compared with the culture method

Ann Clin Microbiol 2022;25:147-154. Evaluation of the Biofire Filmarray pneumonia panel for the detection of bacterial respiratory pathogens and antimicrobial resistance genes in endotracheal aspirate specimens Pathogen Culture (+) Culture (+) Culture (-) Culture (-) FA-PE (+) FA-PE (-) FA-PE (+) FA-PE (-) Gram-positive bacteria Staphylococcus aureus 4 0 0 Streptococcus pyogenes 1 0 0 […]

Table 1. BioFire FilmArray pneumonia panel detection target pathogens and antibacterial resistance genes

Ann Clin Microbiol 2022;25:147-154. Evaluation of the Biofire Filmarray pneumonia panel for the detection of bacterial respiratory pathogens and antimicrobial resistance genes in endotracheal aspirate specimens Category Target Bacteria (Semi-quantitative) Acinetobacter calcoaceticus-baumannii complex Enterobacter cloacae complex Escherichia coli Haemophilus influenzae Klebsiella aerogenes Klebsiella oxytoca Klebsiella pneumoniae group Moraxella catarrhalis Proteus spp. Pseudomonas aeruginosa Serratia marcescens […]